Home
About Us
About MediRama
Mission & Vision
Why MediRama
Leadership team
MD Professional
Core Service
What does
MediRama do?
Resources
Publication & News
Events & Webinars
Careers
Careers
Contact us
ENG
KOR
ENG
Resources
Resources
[MediRama EDGE] When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.
Writer:
관리자
Date:
2026-03-03
When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.
송출일 : 2026.02.26
https://www.youtube.com/watch?v=5ZMexgAGs4A
PREV
[MediRama EDGE] A Review of Clinical Pharmacology Considerations in Antibody–Drug Conjugates Approved by the US Food and Drug Administration Between 2000 and 2025.
[MediRama EDGE] BCMA BiTE (Teclistamab) deeper into multiple myeloma.
NEXT
LIST
Share
LINE
BAND
Naver
Faceboox
X
Copy